Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
AssigneeTakeda Vaccines, Inc.
InventorsCharles Richardson, Robert F. Bargatze, Joel Haynes, Bryan Steadman
Life of this patent
Estimating the term…
Loading patent…
AssigneeTakeda Vaccines, Inc.
InventorsCharles Richardson, Robert F. Bargatze, Joel Haynes, Bryan Steadman
Estimating the term…
The present invention provides polypeptides having a composite amino acid sequence derived from a consensus sequence representing the capsid proteins of two or more circulating strains of a non-enveloped virus. In particular, the invention provides virus-like particles comprising at least one composite polypeptide. Such virus-like particles have antigenic epitopes of two or more circulating strains of a non-enveloped virus and produce an increase in antisera cross-reactivity to one or more circulating strains of the non-enveloped virus. Methods of making composite virus-like particles and vaccine formulations comprising composite virus-like particles are also disclosed.
A virus-like particle comprising at least one polypeptide having a composite amino acid sequence, wherein said composite amino acid sequence comprises SEQ ID NO:
A method of making a virus-like particle comprising:
Dependencies are inferred from the claim text.